Document is current
Any future updates will be listed below
-
Authors
Villanueva, B.
Figueras, A.
Torres-Iglesias, R.
Muñoz, M.
Moreno-Lopes, S.
Trullén-Malaret, N.
Martínez, A.
Viñals, F.
Riera-Mestre, A. https://orcid.org/0000-0001-9411-804X
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III
European Commission
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Evolution of angiogenic and inflammatory biomarkers in patients with hereditary hemorrhagic telangiectasia during treatment with bevacizumab: study protocol
Journal Title: Revista Clínica Española (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2025.502370
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2025.502370
Content Type: article
Copyright: © 2025 The Author(s). Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
